<DOC>
	<DOCNO>NCT02831062</DOCNO>
	<brief_summary>This study evaluate patient episode moderate severe acute kidney injury ( AKI ) follow focused post-AKI clinic . After patient present sign kidney recovery hospital discharge , patient give consent enrol study . At first post-AKI clinic visit , patient randomly allocate follow normal ( ad-lib ) low protein diet ( LPD ) 3 month . Patients allocate LPD receive drug call Ketosteril . This drug allow intake essential amino acid minimize amino-nitrogen intake , excess , bad recover kidney . The investigator evaluate nutritional parameter kidney recovery patient compare parameter two group .</brief_summary>
	<brief_title>Nutritional Therapy Prevent Progression Acute Kidney Injury Chronic Kidney Disease</brief_title>
	<detailed_description>This pilot single center , randomize control , trial patient episode Stage 2/3 AKI follow focused post-AKI clinic . Patients randomize either ; a. LPD-K diet contain 0.6 g protein/kg per day , phosphorus 5-10 mg/kg/day , Ketosteril 1 capsule per 5 kg body weight/day divide three dos ( max 8 capsule per dose ) b. ad lib diet . Ketosteril take daily meal tablet must chew . Ingestion meal facilitate proper absorption metabolisation correspond amino acid . After initial assessment , randomize LPD-K diet maximum 90 day . Additional intervention include dietary counselling questionnaire group . We would aim maintain serum bicarbonate level ≥ 22meq/L group . Evaluation renal function perform use blood urine test . In addition , specimen collect bio-repository , test biomarkers renal structural damage . Comprehensive nutritional assessment perform dietitian , along bioelectrical impedance measurement , blood urine test . 24-hour urine urea nitrogen food record use estimate protein intake individual . Quality well-being assess use standardized tool Euro Quality Life ( EQ-5D ) , Charlson Index , Short Form 8 ( SF8 ) equivalent . Relevant clinical event ( adherence follow-up , death , hospitalization , renal recovery , repeat AKI episodes ) track throughout study .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Disease Progression</mesh_term>
	<mesh_term>Acute Kidney Injury</mesh_term>
	<criteria>Duration stage 2/3 AKI episode ≥ 72 hr ≤ 21 day Total hospital stay ≤ 21 day Baseline Chronic Kidney Disease Stage 4 high ( estimate Glomerular Filtration Rate ( eGFR ) ) &lt; 30ml/min/1.73m2 ) prior AKI episode Patients dialysis dependent hospital discharge Dialysis dependency &gt; 14 day time enrolment eGFR exclusion criterion : patient require dialysis hospital stay measure GFR le 15ml/min and/or urine output le 500ml hospital discharge patient know baseline serum creatinine ( SCr ) renal recovery eGFR 80 % baseline hospital discharge patient unknown previous renal function eGFR &gt; 60ml/min/1.73m2 time hospital discharge Suspected biopsy proven glomerulonephritis cause AKI Obstructive nephropathy cause AKI . Kidney transplant recipient patient kidney transplant list Chronic liver disease High likelihood rehospitalization death follow 6 month , ascertain physician charge patient . Hypercalcemia Ca &gt; within one standard deviation reference level upper limit albumin correct Lactating pregnant woman woman plan become pregnant within timeframe study Inability follow study procedure least 6 month Unwillingness give consent Institutionalized individual ( prisoner , significant mental illness , nursing home resident ) Body weight &lt; 70 % &gt; 150 % standard body weight History phenylketonuria major disorder amino acid metabolism Hypersensitivity active substance excipients Ketosteril .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>nutrition</keyword>
	<keyword>progression</keyword>
</DOC>